NeuroDerm Stock Doubles on Success of New Parkinson’s Drug

Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, ended the year on a really high note as its stock more than doubled in value this More...

Israeli NeuroDerm Announces Success in New Parkinson’s Treatment

NeuroDerm, an Israeli clinical-stage pharmaceutical company, announced that patients with moderate to severe Parkinson’s disease who received continuous, subcutaneous doses of liquid levodopa/carbidopa More...